Beckman Coulter Diagnostics improves patient care with synergistic immunoassay and microbiology solutions

Beckman Coulter Immunoassay and Beckman Coulter Microbiology have joined forces at ESCMID Global to introduce the DxI 9000 Immunoassay Analyzer where the company launched a brand-new suite of blood virus assays to the public. This new suite of assays complements the Microbiology portfolio to provide mechanisms for early detection and confirmation of bacterial and viral infections to improve patient outcomes. Discover how Beckman Coulter Diagnostics is transforming the landscape of diagnostic testing, offering a patient-centric approach with unprecedented accuracy, efficiency, and reliability.

This video was filmed at ESCMID Global 2024.